JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 103 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $104,423 | -35.1% | 15,379 | -20.1% | 0.00% | – |
| Q4 2021 | $161,000 | +9.5% | 19,249 | -2.7% | 0.00% | – |
| Q3 2021 | $147,000 | +23.5% | 19,784 | +71.2% | 0.00% | – |
| Q1 2021 | $119,000 | +24.0% | 11,555 | -1.8% | 0.00% | – |
| Q3 2020 | $96,000 | +11.6% | 11,765 | 0.0% | 0.00% | – |
| Q2 2020 | $86,000 | +56.4% | 11,765 | +1.3% | 0.00% | – |
| Q1 2020 | $55,000 | +587.5% | 11,617 | +1055.9% | 0.00% | – |
| Q2 2018 | $8,000 | -97.0% | 1,005 | -91.5% | 0.00% | – |
| Q1 2018 | $264,000 | +64.0% | 11,829 | -6.5% | 0.00% | – |
| Q4 2017 | $161,000 | -14.8% | 12,654 | +4.1% | 0.00% | – |
| Q3 2017 | $189,000 | +9350.0% | 12,151 | +10110.9% | 0.00% | – |
| Q2 2017 | $2,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |